Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Thalassemic patients often suffer from iron overload due to frequent blood transfusion. Oral
iron chelators reduce iron overload in transfusion dependent patients. The aim of this study
is to compare the efficacy and safety of osveral and desferal in transfusional iron overload
patients with β-Thalassemia and intermediate Thalassemia in Bandarabbas.